The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecureâ„¢ defibrillation lead. Now ...
Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
This release is available in Chinese. New research indicates that a finding on a routine electrocardiogram that signals a disorder of the electrical conducting system in one part of the heart and ...
Heart rhythm problems occur when heart muscle cells fail to properly transmit electrical signals that coordinate blood pumping. Now, scientists at Duke University have devised a promising method to ...
Electrical problems in the heart can often lead to serious and fatal complications including complete heart block or heart failure. Left ventricular conduction disease occurs when there is an ...
During a severe heart attack many heart muscle cells die and are replaced by scar tissue to stabilize the heart wall. Connective tissue cells, known as fibroblasts (FB), are the dominant cell type in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results